ELDN Eledon Pharmaceuticals, Inc.
$2.76▲ +14.52%
Healthcare
Other
After hours
$2.74▼ -0.72%
Oct 28, 6:45 PM ET
Volume 2.08M
Avg Volume (10D) 731.4K
Key Metrics & Fundamentals
Market Cap
$224.28M
P/E Ratio
–
Div Yield
0.00%
52W Range
1.35 - 4.60
% vs 50 MA
1.84%
% vs 200 MA
-10.89%
RSI-14
62.5
MACD Histogram
+0.0600
Beta (1Y vs SPY)
1.72
Free Cash Flow
-$22.68M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$13.25M
COGS
–
Operating Exp
$22.87M
Operating Income
-$22.87M
EBIT
-$22.87M
Pretax Income
-$31.63M
Net Income
-$31.63M
EPS (Diluted)
-0.27
Price & Volume History
Loading chart…
Recent News
Eledon Pharmaceuticals Presents Phase 2 BESTOW Trial Data Showing Sustained Improvements in Quality of Life and Symptom Burden with Tegoprubart Compared to Tacrolimus at American Society of Nephrology Kidney Week 2026 Annual Meeting
GlobeNewswire · Oct 26, 2026 7:00 AM ET
Eledon Pharmaceuticals Announces Presentation at the American Society of Nephrology Kidney Week 2026 Annual Meeting
GlobeNewswire · Oct 5, 2026 4:05 PM ET
Eledon Presents Updated Long-Term Phase 2 BESTOW Extension Study Results at the International Congress of The Transplantation Society
GlobeNewswire · Sep 22, 2026 7:00 AM ET
Top Premarket Gainers
MT Newswires · Sep 11, 2026 7:14 AM ET
Eledon Pharmaceuticals Announces Presentation at the International Congress of The Transplantation Society
GlobeNewswire · Sep 9, 2026 7:00 AM ET
Eledon Pharmaceuticals Submits IND Application to US FDA for Tegoprubart
MT Newswires · Sep 3, 2026 7:49 AM ET
Eledon Pharmaceuticals Announces Islet Cell Transplantation IND Submission, First Patients Enrolled in Multiple Transplant Programs, and Reaffirms Plan to Initiate Phase 3 Kidney Transplantation Trial in Fourth Quarter 2026
GlobeNewswire · Sep 3, 2026 7:00 AM ET
Eledon Pharmaceuticals Reports Second Quarter 2026 Financial Results and Recent Business Highlights
GlobeNewswire · Aug 13, 2026 4:05 PM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See ELDN's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.